What is the prognosis for Myxofibrosarcoma?
The overall survival of those patients with myxofibrosarcoma was significantly better than other types of STS, with 5-year survival being 63% versus 57% for all presentations ( , Figure 2). Metastases were present at diagnosis in 6 patients ( , 4%) and developed subsequently in 35 patients ( , 20%).
What is the survival rate of epithelioid sarcoma?
Five year survival and ten year survival rate for patients with epithelioid sarcoma are approximately 50-70% and 42-55% respectively. Gender, site, age of diagnosis, tumor size and microscopic pathology have been shown to affect prognosis.
What is low grade Myxofibrosarcoma?
Low grade fibromyxoid sarcoma (LGFMS) is a distinctive variant of fibrosarcoma [9]. It is characterized by an admixture of collagenized hypocellular zones and more cellular myxoid nodules. Tumour cells are usually small, with scanty eosinophilic cytoplasm, round to ovoid nuclei and absent nucleoli.
What is low grade Fibromyxoid sarcoma?
Low-grade fibromyxoid sarcoma (LGFMS) is a distinctive slow growing soft tissue neoplasm, mostly affecting young individuals with no gender difference. It usually arises in deep soft tissue of the lower limbs and trunk, but few cases of LGFMS located in pelvis have been reported.
How common is Myxofibrosarcoma?
Myxofibrosarcoma is a rare soft tissue sarcoma (STS) with an estimated incidence <0.1/100.000/years [1]. Historically, it was first described in 1977 as a part of the spectrum of myxoid fibroblastic malignancies [2, 3].
Is Myxofibrosarcoma malignant?
Myxofibrosarcoma (MFS) is a variant of the group of malignant fibrous histiocytomas. It is one of the most aggressive types of soft tissue neoplasms.
What is a Fibromyxoid sarcoma?
FY-broh-MIK-soyd sar-KOH-muh) A rare, slow-growing type of cancer that usually forms in the deep soft tissues of the legs or trunk (chest and abdomen). The cancer may come back many years after treatment and spread to the lungs and the lining of the wall of the chest cavity.
What is low grade sarcoma?
Your doctor may describe your sarcoma as low grade (grade 1) or high grade (grade 2 or 3). Grade is important because it tells you how the cancer is likely to behave. A low grade cancer is likely to be slower growing and less likely to spread to another part of the body.
What causes Fibromyxoid sarcoma?
DNA mutations in soft tissue sarcoma are common. But they’re usually acquired during life rather than having been inherited before birth. Acquired mutations may result from exposure to radiation or cancer-causing chemicals. In most sarcomas, they occur for no apparent reason.
What does low grade sarcoma mean?
A low grade cancer is likely to be slower growing and less likely to spread to another part of the body. A high grade cancer is likely to be faster growing and is more likely to spread than a low grade sarcoma. The grade is one of the things your doctors need to know to work out the stage of your sarcoma.
What is the prognosis of low-grade fibromyxoid sarcoma?
Low-Grade Fibromyxoid Sarcoma are mostly slow-growing and do not present pain, in most cases. The treatment of choice for Low-Grade Fibromyxoid Sarcoma is a complete surgical excision. The prognosis of Low-Grade Fibromyxoid Sarcoma depends upon several factors including the location, size, and stage of the tumor.
What is the difference between myxofibrosarcoma and fibromyxoid sarcoma?
Clinically, low-grade myxofibrosarcoma tends to occur in the superficial soft tissues of elderly patients, whereas low-grade fibromyxoid sarcoma is usually situated in the deep soft tissues of young adults.
Is fibromyxoid sarcoma painful?
Low-Grade Fibromyxoid Sarcoma are mostly slow-growing and do not present pain, in most cases. Tumor recurrence and metastasis to the lungs may take place several years after initial treatment (including surgical removal) The treatment of choice for Low-Grade Fibromyxoid Sarcoma is a complete surgical excision.
What is mFS (soft tissue sarcoma)?
An MFS may lie just below the skin or deeper in muscle tissue. MFS is not as well-known or understood as many other types of cancer, partly because the features distinguishing it from another soft tissue sarcoma came into focus only recently. Also, an MFS is often mistaken for a benign tumor and treated as such, by removing only the visible growth.